Author pages are created from data sourced from our academic publisher partnerships and public sources.
Mortality in heroin-assisted treatment in Switzerland 1994-2000.
- J. Rehm, U. Frick, C. Hartwig, F. Gutzwiller, P. Gschwend, A. Uchtenhagen
- Drug and alcohol dependence
- 1 August 2005
BACKGROUND A major goal of heroin-assisted treatment in Switzerland has been to reduce the drug-related mortality of heroin users. Therefore, a continuous monitoring of deaths under treatment is… Expand
Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study
BACKGROUND Heroin-assisted substitution treatment for severely opioid-dependent drug users has been available in Switzerland since 1994. Our aim was to ascertain the feasibility, safety, and efficacy… Expand
Evaluating Long-Term Effects of Heroin-Assisted Treatment: The Results of a 6-Year Follow-Up
- F. Güttinger, P. Gschwend, B. Schulte, J. Rehm, A. Uchtenhagen
- European Addiction Research
- 24 March 2003
Since January 1994, heroin-assisted treatment for opiate addicts has been available in Switzerland. This is the first report of the long-term effects of this form of treatment. The report examines… Expand
Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002
- M. Gerlich, P. Gschwend, Ambros Uchtenhagen, A. Kraemer, J. Rehm
- European Journal of Epidemiology
- 21 July 2006
Background : Hepatitis C virus (HCV) remains very prevalent in injection drug users (IDUs). In spite of recommended vaccinations against hepatitis A virus (HAV) and hepatitis B virus (HBV), many IDUs… Expand
What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing?
- G. Bammer, W. van den Brink, P. Gschwend, V. Hendriks, J. Rehm
- Drug and alcohol review
- 1 September 2003
Following on from last edition's Harm Reduction Digest on drug consumption facilities this Digest investigates what can be learnt from the Swiss and Dutch trials of heroin prescribing about the… Expand
[Heroin-assisted treatment of opioid addicts in Switzerland from 1994-2001--utilisation and characteristics of admissions and discharges].
- P. Gschwend, J. Rehm, S. Eschmann, A. Uchtenhagen
- Gesundheitswesen (Bundesverband der Arzte des…
BACKGROUND OBJECTIVES Since the beginning of the 1990 s the number of treated opioid addicts has markedly increased in Switzerland. This study examines the cause of health service utilisation of one… Expand
Complaints of heroin-maintained patients: A survey of symptoms ascribed to diacetylmorphine.
- K. Dürsteler-MacFarland, R. Stohler, +5 authors J. Rehm
- Drug and alcohol dependence
- 28 February 2006
Prescribing of injectable diacetylmorphine (DAM) for heroin dependence has raised concerns about its safety. In light of various reports by heroin-maintained patients of DAM-related adverse events,… Expand
Dosage Regimes in the Prescription of Heroin and Other Narcotics to Chronic Opioid Addicts in Switzerland – Swiss National Cohort Study
Aims: Within the guidelines of the research programme on medical prescription of narcotics for opioid addicts (PROVE), heroin, morphine, and methadone were prescribed to heavily opioid addicted… Expand
Development of a monitoring system for heroin-assisted substitution treatment in Switzerland
SummaryObjectivesSwitzerland introduced heroin-assisted treatment as a routine treatment for drug addicts. As a result the evaluation instruments were changed from a detailed scientific project to a… Expand
Heroingestützte Behandlung für Opioidabhängige in der Schweiz von 1994-2001: Inanspruchnahme und Charakteristik der Ein- und Austretenden
Background objectives: Since the beginning of the 1990 s the number of treated opioid addicts has markedly increased in Switzerland. This study examines the cause of health service utilisation of one… Expand